The composition alteration of gut microbiota in lung cancer: a systematic review and meta-analysis
Frontiers in Microbiology · 20.07.2026 · 17
DOI: 10.3389/fmicb.2026.1873706 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Microbiology, online erschienen am 20.07.2026. Verfasst von Xiaona Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Central Laboratory, Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences, Qingdao, China. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The association between the gut microbiota and lung cancer remains understudied. In this study, we conducted a comprehensive systematic review and meta-analysis to quantitatively synthesize evidence from multiple cohorts to identify robust and consistent alterations in gut microbial diversity and taxonomy associated with lung cancer.
Methods
A systematic literature search was performed across PubMed, Cochrane Library, Embase, and Web of Science databases up to June 5, 2025. The analysis summarized key microbiota characteristics from the selected studies, including alpha diversity, beta diversity, and relative taxonomic abundance. This meta-analysis was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines.
Results
Our systematic search identified 12,810 articles, out of which 27 studies comprising 2,263 individuals, involving 1,234 lung cancer patients and 1,029 non-cancer controls, were included for qualitative synthesis. Meta-analysis revealed a significant reduction in microbial alpha diversity of 25 studies in lung cancer patients. Significant decreases were indicated in the ACE index (SMD = −0.64, 95% CI: −1.14 to −0.13), Chao1 index (SMD = −0.31, 95% CI: −0.60 to −0.02), and Shannon index (SMD = −0.25, 95% CI: −0.57 to 0.08). Chinese cohorts showed significantly lower Chao1and Shannon by subgroup analysis. Twenty-seven studies assessed beta diversity, in which 20 studies (74.0%) reported a significant difference in overall microbial community structure between lung cancer patients and non-cancer controls. Quantitative meta-analysis by forest plot revealed, compared to non-cancer controls, lung cancer patients exhibited decreased relative abundances of phylum Firmicutes (SMD = −0.47, 95% CI: −0.91 to −0.02), and increased abundances of phylum Bacteroidetes (SMD = 0.53, 95% CI: 0.24 to 0.82). Furthermore, we observed a marked depletion of beneficial short-chain fatty acid producers of genus Lachnospira (SMD = −1.01, 95% CI: −1.29 to −0.73).
Conclusion
This meta-analysis demonstrates that lung cancer is consistently associated with gut microbiota dysbiosis characterized by reduced microbial diversity and reproducible taxonomic alterations. Clinically, these findings suggest that gut microbiota may serve as non-invasive biomarkers for lung cancer detection and patient stratification, and may also help predict immunotherapy response and inform future microbiota-targeted therapeutic strategies. Systematic review registration https://www.crd.york.ac.uk/PROSPERO/view/CRD42024537463 , CRD42024537463.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Central Laboratory, Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences, Qingdao, China.
- Qingdao Traditional Chinese Medicine Hospital, Qingdao Hiser Hospital Affiliated of Qingdao University, Qingdao, China.
- School of Medical Laboratory, Shandong Second Medical University, Weifang, China.
- Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao, China.
- Clinical Research Center, Qingdao Key Laboratory of Common Diseases, Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences, Qingdao, China.
- Human Resources Department, Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences, Qingdao, China.
Zitieren
APA
Xu, X., Yu, T., Wu, H., Guo, Y., Li, M., Han, Y., Zhao, L., & Yu, X. (2026). The composition alteration of gut microbiota in lung cancer: a systematic review and meta-analysis. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1873706
Vancouver
Xu X, Yu T, Wu H, Guo Y, Li M, Han Y, et al. The composition alteration of gut microbiota in lung cancer: a systematic review and meta-analysis. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1873706
BibTeX
@article{Xu2026,
author = {Xu, Xiaona and Yu, Ting and Wu, Hongying and Guo, Yang and Li, Meng and Han, Yaozu and Zhao, Lei and Yu, Xinjuan},
title = {The composition alteration of gut microbiota in lung cancer: a systematic review and meta-analysis},
journal = {Frontiers in Microbiology},
year = {2026},
volume = {17},
doi = {10.3389/fmicb.2026.1873706}
}
EUVIMED